
Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults
...

...

From - Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…

From - Diagnostic Testing & Emerging Technologies
The U.S. Centers for Disease Control and Prevention (CDC) announced a…

From - Diagnostic Testing & Emerging Technologies
Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is…

From - Diagnostic Testing & Emerging Technologies
The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for…